Ranraft 133.5mg Oral Suspension Mint
By Ranraft
Rx
150ml Oral Suspension in a Bottle

Composition
Sodium Bicarbonate(133.5mg)

Manufacturer - J B Chemicals and Pharmaceuticals Ltd
Cnergy IT Park, 3rd floor Appa Saheb Marathe Marg, Prabhadevi, Mumbai 400025

Expires on or after
October, 2025

liver
When using Ranraft 133.5mg Oral Suspension Mint, it is important to be cautious if you have liver disease. Patients with liver issues may require an adjustment in the dosage of this medication. It is advisable to consult your doctor before starting or continuing the use of Ranraft 133.5mg Oral Suspension Mint to ensure safe and appropriate treatment.

kidney
Caution Ranraft 133.5mg Oral Suspension Mint should be used carefully in patients with kidney disease. Adjusting the dosage may be necessary. Always seek advice from a doctor.

alcohol
It is not safe to drink alcohol while taking Ranraft 133.5mg Oral Suspension Mint. This combination can have harmful effects. Consult your doctor when consuming alcohol with this medication.

driving
Ranraft 133.5mg Oral Suspension Mint typically doesn't impact driving ability.

pregnancy
Avoid using Ranraft 133.5mg Oral Suspension Mint during pregnancy as it may be harmful to your baby. Limited human studies exist, but animal studies indicate risks. Your doctor will assess benefits versus risks before prescribing. Consult your doctor for guidance.

breastfeeding
It is better to consult your doctor before using Ranraft 133.5mg Oral Suspension Mint.
Habit Forming | No |
Chemical Class | Organic Carbonic Acids |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Antacids |
₹186.91
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024